Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025 21.8% Revenue growth, 20252 Where the money goes Where each dollar of revenue went, fiscal 2025 Cost of revenue Other costs
Cost of revenue 13¢ $40.1K Other costs 87¢ $262.9K Out of $303.0K in revenue.2 The company lost money this year.
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 2 $303.0K in 2025−4% since 2023 0 $100.0K $200.0K $300.0K $400.0K 2023: $316.8K $316.8K 2023 2024: $248.8K $248.8K 2024 −21% 2025: $303.0K $303.0K 2025 +22% Gross profit4 2 $262.9K in 2025+18% since 2023 0 $100.0K $200.0K $300.0K 2023: $223.4K $223.4K 2023 2024: $203.2K $203.2K 2024 −9% 2025: $262.9K $262.9K 2025 +29% Operating income4 2 -$421.4K in 2025−57% since 2023 -$1.0M -$750.0K -$500.0K -$250.0K 0 2023: -$983.4K -$983.4K 2023 2024: -$486.1K -$486.1K 2024 −51% 2025: -$421.4K -$421.4K 2025 −13% Net income4 2 -$548.8K in 2025−47% since 2023 -$1.5M -$1.0M -$500.0K 0 2023: -$1.0M -$1.0M 2023 2024: -$651.3K -$651.3K 2024 −37% 2025: -$548.8K -$548.8K 2025 −16%
Revenue5 6 $11.2K in Q3 FY2026−79% since Q2 FY2025 0 $20.0K $40.0K $60.0K Q2 FY2025: $53.3K $53.3K Q2 FY2025 Q3 FY2026: $11.2K $11.2K Q3 FY2026 −79% Gross profit5 6 $8.2K in Q3 FY2026−81% since Q2 FY2025 0 $20.0K $40.0K $60.0K Q2 FY2025: $42.8K $42.8K Q2 FY2025 Q3 FY2026: $8.2K $8.2K Q3 FY2026 −81% Operating income5 6 -$93.3K in Q3 FY2026−3% since Q2 FY2025 -$100.0K -$75.0K -$50.0K -$25.0K 0 Q2 FY2025: -$95.9K -$95.9K Q2 FY2025 Q3 FY2026: -$93.3K -$93.3K Q3 FY2026 −3% Net income5 6 -$103.9K in Q3 FY2026+26% since Q2 FY2025 -$150.0K -$100.0K -$50.0K 0 Q2 FY2025: -$82.6K -$82.6K Q2 FY2025 Q3 FY2025: -$82.6K -$82.6K Q3 FY2025 +0% Q2 FY2025: -$117.0K -$117.0K Q2 FY2025 +42% Q3 FY2025: -$117.0K -$117.0K Q3 FY2025 +0% Q3 FY2026: -$103.9K -$103.9K Q3 FY2026 −11%
Fiscal year 2022 2023 2024 2025 Revenue $316.8K4 $248.8K2 $303.0K2 Cost of revenue $93.5K4 $45.6K2 $40.1K2 Gross profit $223.4K4 $203.2K2 $262.9K2 Operating income -$983.4K4 -$486.1K2 -$421.4K2 Income tax $04 $04 Net income -$1.0M4 -$651.3K2 -$548.8K2 Earnings per share -$0.004 -$0.002 -$0.002 Earnings per share (diluted) -$0.004 -$0.002 -$0.002
Total assets4 2 $31.9K in 2025−27% since 2023 0 $20.0K $40.0K $60.0K 2023: $43.4K $43.4K 2023 2024: $57.2K $57.2K 2024 +32% 2025: $31.9K $31.9K 2025 −44% Total liabilities4 2 $1.2M in 2025+88% since 2023 0 $500.0K $1.0M $1.5M 2023: $635.0K $635.0K 2023 2024: $1.1M $1.1M 2024 +79% 2025: $1.2M $1.2M 2025 +5% Shareholders’ equity4 2 -$1.2M in 2025+222% since 2022 -$1.5M -$1.0M -$500.0K 0 2022: -$361.1K -$361.1K 2022 2023: -$591.7K -$591.7K 2023 +64% 2024: -$1.1M -$1.1M 2024 +82% 2025: -$1.2M -$1.2M 2025 +8% Cash4 2 $13.0K in 2025−60% since 2022 0 $10.0K $20.0K $30.0K $40.0K 2022: $32.0K $32.0K 2022 2023: $8.9K $8.9K 2023 −72% 2024: $755 $755 2024 −92% 2025: $13.0K $13.0K 2025 +1615% Long-term debt4 2 $249.5K in 2025+0% since 2023 0 $100.0K $200.0K $300.0K 2023: $249.5K $249.5K 2023 2024: $249.4K $249.4K 2024 −0% 2025: $249.5K $249.5K 2025 +0%
Total assets5 6 $1.5K in Q3 FY2026−93% since Q2 FY2025 0 $10.0K $20.0K $30.0K Q2 FY2025: $22.1K $22.1K Q2 FY2025 Q3 FY2026: $1.5K $1.5K Q3 FY2026 −93% Total liabilities5 6 $1.5M in Q3 FY2026+6% since Q2 FY2025 0 $500.0K $1.0M $1.5M Q2 FY2025: $1.4M $1.4M Q2 FY2025 Q3 FY2026: $1.5M $1.5M Q3 FY2026 +6% Shareholders’ equity5 6 -$1.5M in Q3 FY2026+18% since Q2 FY2025 -$1.5M -$1.0M -$500.0K 0 Q2 FY2025: -$1.2M -$1.2M Q2 FY2025 Q3 FY2025: -$1.2M -$1.2M Q3 FY2025 +0% Q2 FY2025: -$1.4M -$1.4M Q2 FY2025 +9% Q3 FY2025: -$1.4M -$1.4M Q3 FY2025 +0% Q3 FY2026: -$1.5M -$1.5M Q3 FY2026 +8% Cash5 6 $90 in Q3 FY2026−32% since Q2 FY2025 0 $50 $100 $150 Q2 FY2025: $132 $132 Q2 FY2025 Q3 FY2026: $90 $90 Q3 FY2026 −32% Long-term debt5 6 $249.5K in Q3 FY2026+0% since Q2 FY2025 0 $100.0K $200.0K $300.0K Q2 FY2025: $249.5K $249.5K Q2 FY2025 Q3 FY2026: $249.5K $249.5K Q3 FY2026 +0%
Fiscal year 2022 2023 2024 2025 Cash $32.0K4 $8.9K2 $7552 $13.0K2 Current assets $19.5K4 $21.5K2 $29.1K2 Total assets $43.4K4 $57.2K2 $31.9K2 Current liabilities $385.5K4 $881.9K2 $946.0K2 Long-term debt $249.5K4 $249.4K2 $249.5K2 Total liabilities $635.0K4 $1.1M2 $1.2M2 Shareholders’ equity -$361.1K4 -$591.7K2 -$1.1M2 -$1.2M2 Shares outstanding 10.1B shares4 10.4B shares4 11.6B shares2
Cash from operations4 2 -$329.6K in 2025−63% since 2023 -$1.0M -$750.0K -$500.0K -$250.0K 0 2023: -$898.4K -$898.4K 2023 2024: -$479.4K -$479.4K 2024 −47% 2025: -$329.6K -$329.6K 2025 −31%
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2022 2023 2024 2025 Cash from operations -$898.4K4 -$479.4K2 -$329.6K2
Compare Cannabis Bioscience International Holdings, Inc. with another company
Former names
CHINA INFRASTRUCTURE CONSTRUCTION Corp Sep 29, 2009 to Aug 24, 20223 FIDELITY AVIATION CORP Sep 25, 2007 to Sep 15, 20093
Recent filings
Aug 31, 2026 NT 10-K FORM 10-K EXTENSIONJul 1, 2026 253G2 May 21, 2026 253G2 May 11, 2026 144 Apr 16, 2026 10-Q FORM 10-Q FEB 2026Apr 15, 2026 253G2 Apr 14, 2026 NT 10-Q EXTENSIONApr 13, 2026 QUALIF Apr 8, 2026 CORRESP Apr 1, 2026 UPLOAD Mar 27, 2026 1-A Feb 19, 2026 10-Q FORM 10-Q FOR NOV 2025Jan 14, 2026 NT 10-Q EXTENSIONOct 22, 2025 10-Q FORM 10-Q FOR AUGUST 2025Oct 15, 2025 NT 10-Q EXTENSION
Every filing from the last three years, summarized . The full record is on SEC EDGAR.1